首页> 外文期刊>Seminars in radiation oncology >Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer
【24h】

Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer

机译:乳腺癌中核心微转移酶的病理评价和预后意义

获取原文
获取原文并翻译 | 示例
       

摘要

Using modern sentinel lymph node techniques, occult nodal metastases including micro metastases or isolated tumor cells are being increasingly discovered in up to 10% of early stage breast cancers. Furthermore, the rate of nonsentinel lymph node involvement is approximately 10%. However, the impact of these findings on disease-free survival is low, particularly with regards to axillary recurrences. Current evidence suggests small-volume lymph node involvement in breast cancer patients is only one of several factors that should guide adjuvant therapy options. In otherwise favorable patients, adjuvant radiation and systemic therapy can help mitigate the risk of recurrence when omitting axillary lymph node dissection. (C) 2019 The Authors. Published by Elsevier Inc.
机译:使用现代哨兵淋巴结技术,潜水结节转移包括微转移或分离的肿瘤细胞越来越多地发现高达10%的早期乳腺癌。 此外,不列颠淋巴结受累的速率约为10%。 然而,这些发现对无病生存率的影响很低,特别是关于腋生复发。 目前的证据表明,小体积的淋巴结受累乳腺癌患者只是应该引导佐剂治疗方案的几个因素之一。 在其他有利的患者中,佐剂辐射和全身疗法可以帮助减轻腋窝淋巴结解剖时复发的风险。 (c)2019年作者。 elsevier公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号